<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1646-706X</journal-id>
<journal-title><![CDATA[Angiologia e Cirurgia Vascular]]></journal-title>
<abbrev-journal-title><![CDATA[Angiol Cir Vasc]]></abbrev-journal-title>
<issn>1646-706X</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Angiologia e Cirurgia Vascular]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1646-706X2013000100003</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Doença Arterial Periférica e Qualidade de Vida]]></article-title>
<article-title xml:lang="en"><![CDATA[Peripheral Arterial Disease and Quality of Life]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vaz]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[Vera]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[Ana Rita]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valente]]></surname>
<given-names><![CDATA[Paulo]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paúl]]></surname>
<given-names><![CDATA[Constança]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bastos]]></surname>
<given-names><![CDATA[Rui]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[Clara]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loureiro]]></surname>
<given-names><![CDATA[Tiago]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Loureiro]]></surname>
<given-names><![CDATA[Luís]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[Diogo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[Sérgio]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rego]]></surname>
<given-names><![CDATA[Duarte]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[Arlindo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[Rui]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro Hospitalar do Porto Hospital de Santo António Serviço de Angiologia e Cirurgia Vascular]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar Unidade de Investigação e Formação sobre Adultos e Idosos]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Centro Hospitalar do Porto Hospital de Santo António Serviço de Anestesiologia]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A04">
<institution><![CDATA[,Centro Hospitalar do Porto Hospital de Santo António Serviço de Angiologia e Cirurgia Vascular]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2013</year>
</pub-date>
<volume>9</volume>
<numero>1</numero>
<fpage>17</fpage>
<lpage>23</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1646-706X2013000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1646-706X2013000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1646-706X2013000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Introdução: Os Cirurgiões Vasculares avaliam o seu sucesso terapêutico através de indicadores objectivos tais como a taxa de mortalidade, morbilidade e permeabilidade. Nas últimas décadas, tem havido uma mudança significativa na avaliação da doença e do seu tratamento dando especial enfase à Qualidade de Vida (QDV). Objectivos: Os objectivos desta investigação foram determinar quais as dimensões mais afectadas e as mais preservadas em relação à qualidade de vida dos doentes com Doença Arterial Periférica. Material e Métodos: Estudo prospectivo desenvolvido no Serviço de Angiologia e Cirurgia Vascular do Hospital de Santo António. Procedeu-se ao estudo de 101 doentes em regime de internamento por doença arterial periférica. Realizou-se um protocolo em três patamares distintos: um pré-protocolo de avaliação inicial com o estudo de dados biográficos, avaliação da prestação de cuidados e condições sócio-familiares. Um segundo protocolo realizado após a alta com variáveis de caracter clínico e um terceiro protocolo realizado em ambiente de consulta externa em que se procedeu à avaliação de determinantes biopsicossociais e à realização de provas de carácter funcional. Resultados: Verificou-se um predomínio do sexo masculino (62,4%), a média de idades foi de 69, 5 anos (desvio padrão de 11,8), 47, 5% dos doentes frequentou o ensino primário e 12,9% dos doentes nunca frequentaram a escola. No que concerne a esfera familiar, esta amostra apresenta uma alargada rede familiar em que a média de filhos foi de 2,9 (desvio padrão de 2,8), todavia é destacar que 9,9 % dos doentes residem sós. A qualidade de vida geral determinada foi de 41,05, valor que comparativamente à qualidade de vida geral da população portuguesa é de aproximadamente metade. Conclusões: A doença arterial periférica sendo uma doença crónica e muitas vezes associada a consequências mutiladoras de ordem física torna compreensível e esperada a sua tradução negativa na qualidade de vida geral dos doentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Introduction: Vascular surgeons evaluate their success through objective indicators such as mortality rates, morbidity and permeability. In recent decades, there has been a significant change in the assessment of the disease and its treatment giving special emphasis to Quality of Life Objectives: The objectives of this research were to determine which dimensions are most affected and the most preserved concerning the quality of life of patients with Peripheral Arterial Disease. Materials and Methods: Prospective study carried out in the Department of Angiology and Vascular Surgery of Hospital de Santo António, 101 inpatients with peripheral arterial disease were studied. We conducted a protocol on three distinct levels: a pre-assessment protocol which included biographical data and evaluation of socio-familiar conditions. A second protocol performed after discharge with clinical variables and a third protocol performed in outpatient environment in which biopsychosocial determinants were studied as well as functional nature tests were performed. Results: 62.4% of the patients were male, the mean age was 69, 5 years (SD = 11.8), 47, 5% of patients attended primary school and 12.9 % of patients have never attended school. Regarding the family sphere, this sample has an extended family network where the average number of children was 2.9 (SD = 2.8), however it is noted that 9.9% of patients were living alone. The general quality of life of this population was 41.05, this value is half of the value of the overall quality of life of Portuguese population Conclusions: Peripheral arterial disease is a chronic disease and often associated with physical mutilation, as result it is understandable and also expected to have a negative impact in the quality of life of the patients.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Qualidade de Vida]]></kwd>
<kwd lng="pt"><![CDATA[Doença Arterial Periférica]]></kwd>
<kwd lng="en"><![CDATA[Quality of Life]]></kwd>
<kwd lng="en"><![CDATA[Peripheral Artery Disease]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ 
	    <p><b>Doen&#231;a Arterial Perif&eacute;rica e Qualidade de Vida</b></p>
	    <p>&nbsp;</p>
    <p><b>Peripheral Arterial Disease and Quality of Life</b></p>
    <p>&nbsp;</p>
        <p><b>Carolina Vaz, Vera Mafalda Duarte*, Ana Rita Santos**, Paulo Valente***, Constan&#231;a Pa&uacute;l*, Rui Bastos**, Clara Nogueira, Tiago Loureiro, Lu&iacute;s Loureiro, Diogo Silveira, S&eacute;rgio Teixeira, Duarte Rego, Arlindo Matos, Rui Almeida</b></p>
        <p>Servi&#231;o de Angiologia e Cirurgia Vascular do Hospital de Santo Ant&oacute;nio,</p>

	    <p>Centro Hospitalar do Porto</p>

	    <p>*Unidade de Investiga&#231;&atilde;o e Forma&#231;&atilde;o sobre Adultos e Idosos,</p>

	    <p>Instituto de Ci&ecirc;ncias Biom&eacute;dicas Abel Salazar, Universidade do Porto</p>

	    ]]></body>
<body><![CDATA[<p>**Servi&#231;o de Anestesiologia,</p>

	    <p>Hospital de Santo Ant&oacute;nio,</p>

	    <p>Centro Hospitalar do Porto</p>
	    <p>***Enfermeiro Chefe do Servi&#231;o de Angiologia e Cirurgia Vascular, Hospital de santo Ant&oacute;nio, Centro Hospitalar do Porto</p>

	    <p>&nbsp;</p>
	    <p>|RESUMO|</p>
        <p><b>Introdu&#231;&atilde;o: </b>Os Cirurgi&otilde;es Vasculares avaliam o seu sucesso terap&ecirc;utico atrav&eacute;s de indicadores objectivos tais como a taxa de mortalidade, morbilidade e permeabilidade. Nas &uacute;ltimas d&eacute;cadas, tem havido uma mudan&#231;a significativa na avalia&#231;&atilde;o da doen&#231;a e do seu tratamento dando especial enfase &agrave; Qualidade de Vida (QDV).</p>
        <p><b>Objectivos: </b>Os objectivos desta investiga&#231;&atilde;o foram determinar quais as dimens&otilde;es mais afectadas e as mais preservadas em rela&#231;&atilde;o &agrave; qualidade de vida dos doentes com Doen&#231;a Arterial Perif&eacute;rica.</p>
        <p><b>Material e M&eacute;todos:</b> Estudo prospectivo desenvolvido no Servi&#231;o de Angiologia e Cirurgia Vascular do Hospital de Santo Ant&oacute;nio. Procedeu&#45;se ao estudo de 101 doentes em regime de internamento por doen&#231;a arterial perif&eacute;rica. Realizou&#45;se um protocolo em tr&ecirc;s patamares distintos: um pr&eacute;&#45;protocolo de avalia&#231;&atilde;o inicial com o estudo de dados biogr&aacute;ficos, avalia&#231;&atilde;o da presta&#231;&atilde;o de cuidados e condi&#231;&otilde;es s&oacute;cio&#45;familiares. Um segundo protocolo realizado ap&oacute;s a alta com vari&aacute;veis de caracter cl&iacute;nico e um terceiro protocolo realizado em ambiente de consulta externa em que se procedeu &agrave; avalia&#231;&atilde;o de determinantes biopsicossociais e &agrave; realiza&#231;&atilde;o de provas de car&aacute;cter funcional.</p>
        <p><b>Resultados:</b> Verificou&#45;se um predom&iacute;nio do sexo masculino (62,4%), a m&eacute;dia de idades foi de 69, 5 anos (desvio padr&atilde;o de 11,8), 47, 5% dos doentes frequentou o ensino prim&aacute;rio e 12,9% dos doentes nunca frequentaram a escola. No que concerne a esfera familiar, esta amostra apresenta uma alargada rede familiar em que a m&eacute;dia de filhos foi de 2,9 (desvio padr&atilde;o de 2,8), todavia &eacute; destacar que 9,9 % dos doentes residem s&oacute;s. A qualidade de vida geral determinada foi de 41,05, valor que comparativamente &agrave; qualidade de vida geral da popula&#231;&atilde;o portuguesa &eacute; de aproximadamente metade.</p>
        ]]></body>
<body><![CDATA[<p><b>Conclus&otilde;es:</b> A doen&#231;a arterial perif&eacute;rica sendo uma doen&#231;a cr&oacute;nica e muitas vezes associada a consequ&ecirc;ncias mutiladoras de ordem f&iacute;sica torna compreens&iacute;vel e esperada a sua tradu&#231;&atilde;o negativa na qualidade de vida geral dos doentes.</p>
        <p><b>Palavras&#173;chave: </b>Qualidade de Vida, Doen&#231;a Arterial Perif&eacute;rica</p>
        <p>&#160;</p>
    <p>|ABSTRACT|</p>

	    <p><b>Introduction:</b> Vascular surgeons evaluate their success through objective indicators such as mortality rates, morbidity and permeability. In recent decades, there has been a significant change in the assessment of the disease and its treatment giving special emphasis to Quality of Life</p>

	    <p><b>Objectives:</b> The objectives of this research were to determine which dimensions are most affected and the most preserved concerning the quality of life of patients with Peripheral Arterial Disease.</p>

	    <p><b>Materials and Methods:</b> Prospective study carried out in the Department of Angiology and Vascular Surgery of Hospital de Santo Ant&oacute;nio, 101 inpatients with peripheral arterial disease were studied. We conducted a protocol on three distinct levels: a pre&#45;assessment protocol which included biographical data and evaluation of socio&#45;familiar conditions. A second protocol performed after discharge with clinical variables and a third protocol performed in outpatient environment in which biopsychosocial determinants were studied as well as functional nature tests were performed.</p>

	    <p><b>Results:</b> 62.4% of the patients were male, the mean age was 69, 5 years (SD = 11.8), 47, 5% of patients attended primary school and 12.9 % of patients have never attended school. Regarding the family sphere, this sample has an extended family network where the average number of children was 2.9 (SD = 2.8), however it is noted that 9.9% of patients were living alone. The general quality of life of this population was 41.05, this value is half of the value of the overall quality of life of Portuguese population</p>

	    <p><b>Conclusions:</b> Peripheral arterial disease is a chronic disease and often associated with physical mutilation, as result it is understandable and also expected to have a negative impact in the quality of life of the patients.</p>

	    <p><b>Key-words:</b> Quality of Life, Peripheral Artery Disease</p>

	    ]]></body>
<body><![CDATA[<p>&#160;</p>
	    <p><b>INTRODU&Ccedil;&Atilde;O</b></p>

	    <p>A Doen&#231;a Arterial Perif&eacute;rica (DAP) caracteriza&#45;se por ser uma doen&#231;a de natureza estenosante/obstrutiva do l&uacute;men arterial resultando num d&eacute;fice de fluxo sangu&iacute;neo aos tecidos tendo como principal consequ&ecirc;ncia a presen&#231;a de sinais e sintomas caracter&iacute;sticos de isquemia. A componente obstrutiva da doen&#231;a &eacute; em 90% dos casos associada a fen&oacute;menos exclusivos de aterosclerose<sup>&#91;1&#93;</sup>. Est&aacute; descrito na literatura que a sua preval&ecirc;ncia varia entre os 3&#45;10% aumentando para 15&#45;20% em adultos com mais de 70 anos<sup>&#91;2&#93;</sup>.Os objectivos do tratamento consistem na preven&#231;&atilde;o dos eventos cardiovasculares, preserva&#231;&atilde;o dos membros afectados promovendo a melhoria da QDV do doente.</p>

	    <p>Qualidade de vida &eacute; definida pela Organiza&#231;&atilde;o Mundial de Sa&uacute;de<sup>&#91;3&#93;</sup> como a percep&#231;&atilde;o do indiv&iacute;duo sobre a sua posi&#231;&atilde;o na vida, dentro do contexto dos sistemas de cultura e valores nos quais est&aacute; inserido e em rela&#231;&atilde;o aos seus objectivos, expectativas, padr&otilde;es e preocupa&#231;&otilde;es. Assim sendo, trata&#45;se de um conceito multidimensional, que assenta numa avalia&#231;&atilde;o de dimens&otilde;es do foro f&iacute;sico, esfera psicol&oacute;gica e padr&atilde;o social dos sujeitos.</p>

    <p>S&atilde;o objetivos desta investiga&#231;&atilde;o perceber quais as dimens&otilde;es que est&atilde;o mais afectadas e mais preservadas em rela&#231;&atilde;o &agrave; qualidade de vida dos doentes com doen&#231;a arterial de forma a estabelecer um perfil psicol&oacute;gico do doente que padece com esta mesma doen&#231;a.</p>

	    <p>&nbsp;</p>
	    <p><b>MATERIAL E M&Eacute;TODOS</b></p>

	    <p>A amostra do presente estudo &eacute; composta por 101 doentes com o diagn&oacute;stico de doen&#231;a arterial perif&eacute;rica em regime de internamento no Servi&#231;o de Angiologia e Cirurgia Vascular do Hospital de Santo Ant&oacute;nio. Foram inclu&iacute;dos todos os doentes internados durante um per&iacute;odo de dois meses e que aceitassem participar no estudo.</p>

	    <p>Procedeu&#45;se a uma investiga&#231;&atilde;o longitudinal que se caracteriza por 3 patamares distintos de avalia&#231;&atilde;o:</p>

	    <p>1) <i>Aplica&#231;&atilde;o de um Pr&eacute; &#45; Protocolo</i> &#45; aquando a admiss&atilde;o do doente no servi&#231;o sendo este constitu&iacute;do pelos dados de identifica&#231;&atilde;o do doente, presen&#231;a/aus&ecirc;ncia de factores de risco cardiovasculares, avalia&#231;&atilde;o da presta&#231;&atilde;o de cuidados e avalia&#231;&atilde;o das condi&#231;&otilde;es s&oacute;cio&#45; familiares.</p>

	    ]]></body>
<body><![CDATA[<p>2) <i>Aplica&#231;&atilde;o do Protocolo de Avalia&#231;&atilde;o</i> &#150; procedeu&#45;se &agrave; consulta do processo do doente com a recolha de dados de ordem cl&iacute;nica.</p>

	    <p>3) <i>Aplica&#231;&atilde;o do Protocolo de Avalia&#231;&atilde;o </i>&#150; aplica&#231;&atilde;o em contexto de consulta, 3 a 6 meses 
	ap&oacute;s a alta sendo composto pelos seguintes dados biocomportamentais: Fluxo Respirat&oacute;rio (Peak Flow), For&#231;a da M&atilde;o 
	(Dinam&oacute;metro), Indicadores de Risco Geri&aacute;trico, &Iacute;ndice de Comorbilidades Charlon<sup>&#91;4&#93;</sup>, 
	Avalia&#231;&atilde;o da Capacidade Funcional &#45;&Iacute;ndice de Actividade de Vida Di&aacute;ria<sup>&#91;5&#93;</sup>, &Iacute;ndice de 
	Actividades de Vida Instrumental de Lawton e Brody<sup>&#91;6&#93;</sup>, Humor &#45; Escala de Depress&atilde;o Geri&aacute;trica (GDS)
	<sup>&#91;7&#93;</sup>, Mini Mental State Examination MMSE<sup>&#91;8&#93;</sup>, Qualidade de Vida<sup>&#91;9&#93;</sup> e a Escala de Avalia&#231;&atilde;o Socio&#45;familiar de Gij&oacute;n<sup>&#91;</sup><sup>10&#93;</sup>. Esta consulta de avalia&#231;&atilde;o final, assumiu um tempo de dura&#231;&atilde;o m&eacute;dio entre 30 a 45 minutos tendo&#45;se procedido igualmente, no mesmo hor&aacute;rio a uma consulta m&eacute;dica, onde se avaliou o status cl&iacute;nico do doente.</p>

    <p>O estudo da qualidade de vida centrou&#45;se na aplica&#231;&atilde;o do WHOQOL&#45; Bref que &eacute; constitu&iacute;do por 26 perguntas distribu&iacute;das por quatro dom&iacute;nios: F&iacute;sico, Psicol&oacute;gico, Rela&#231;&otilde;es Sociais e Ambientais.</p>

	    <p>&#160;	</p>
	    <p><b>RESULTADOS</b></p>

	    <p>A maioria dos doentes estudados eram do sexo masculino (62,4%) e a m&eacute;dia de idades foi de 69,5 anos (dp11,8). No que concerne ao 
	n&iacute;vel educacional 47,5% frequentou o ensino prim&aacute;rio no entanto 12,9% nunca frequentou a escola. No que diz respeito &agrave; 
	esfera familiar, 58,4% dos doentes eram casados, assim como esta amostra apresenta uma alargada rede familiar em que a m&eacute;dia de filhos 
	&eacute; de 2,9 (dp 2,3), a de netos &eacute; de 4,1 (dp 4,6) e a de irm&atilde;os &eacute; de 3,0 (dp 2,8). Sendo que 39,6% dos doentes 
	reside com o conjugue, 16,8% com os filhos e que apesar de se inserirem num seio familiar numeroso 9,9% dos doentes residem 
	sozinhos. |<a href="#t1">TABELA I</a>|.	</p>
	    <p>&nbsp;</p>
	<a name="t1">
	    <p><img src="/img/revistas/ang/v9n1/9n1a03t1.jpg" width="366" height="689"></p>

    
<p>&#160;</p>

    <p>A hipertens&atilde;o arterial (78,2%), a dislipidemia (73,3%) e a diabetes (60,4%) foram os factores de risco cardiovascular mais prevalentes 
nesta amostra. | <a href="#t2">TABELA II</a> |. A arteriopatia Grau IV, segundo a classifica&#231;&atilde;o de Leriche &#45; Fontaine (79,3%, n &#150; 79) foi o 
motivo de internamento mais frequente, seguindo&#45;se pela arteriopatia grau III (15,8%, n&#45;16).</p>
    ]]></body>
<body><![CDATA[<p>&nbsp;</p>
<a name="t2">
    <p><img src="/img/revistas/ang/v9n1/9n1a03t2.jpg" width="363" height="544"></p>

	    
<p>&nbsp;</p>
	    <p>Procedeu&#45;se &agrave; aplica&#231;&atilde;o da escala The Groningen Fragiilty Indicator<sup>&#91;11&#93;</sup> (que nos permite avaliar 
	quais os indicadores de fragilidade mais afectados nesta amostra de doentes com DAP) tendo&#45;se verificado que todas as dimens&otilde;es 
	contempladas pela escala (mobilidade, forma f&iacute;sica e aspectos psicossociais) se encontram fortemente comprometidos. | <a href="#t3">TABELA III</a> |.</p>
	    <p>&nbsp;</p>
	<a name="t3">
	    <p><img src="/img/revistas/ang/v9n1/9n1a03t3.jpg" width="363" height="1058"></p>

	    
<p>&nbsp;</p>
	    <p>&Eacute; importante salientar que 38,8% dos doentes (n &#45;38) foram submetidos a cirurgia de revasculariza&#231;&atilde;o, que 34,6% (n &#150; 35) foram submetidos a cirurgia de revasculariza&#231;&atilde;o e amputa&#231;&atilde;o minor, 23,7% (n&#45;24) foram submetidos exclusivamente a amputa&#231;&atilde;o minor (sem cirurgia de revasculariza&#231;&atilde;o associada) e 2,9% (n&#45;3) dos doentes foram submetidos a amputa&#231;&atilde;o major prim&aacute;ria; 70,3% (n &#45;71) n&atilde;o apresentaram complica&#231;&otilde;es per e p&oacute;s&#45;operat&oacute;rias em 13 (12,9%) doentes foi diagnosticado infec&#231;&atilde;o de ferida operat&oacute;ria e 2 doentes (2%) faleceram durante o internamento.</p>

    <p>Tr&ecirc;s a seis meses ap&oacute;s a alta em ambiente de consulta externa procedeu&#45;se a avalia&#231;&atilde;o de novo dos doentes, sendo de referir que foram na sua totalidade constatados 11 &oacute;bitos (2 em regime de internamento e 9 no domic&iacute;lio), 22 doentes n&atilde;o responderam &agrave;s convocat&oacute;rias de avalia&#231;&atilde;o em regime de consulta externa, cujas circunst&acirc;ncias n&atilde;o foram poss&iacute;veis de apurar ap&oacute;s m&uacute;ltiplas tentativas de contacto, verificando&#45;se portanto a redu&#231;&atilde;o da nossa amostra para 68 doentes.</p>

    <p>Aplicou&#45;se, nesta terceira etapa de avalia&#231;&atilde;o;<br />
	o Mini Mental State Examination (MMSE)<sup>&#91;8&#93;</sup> tendo&#45;se verificado um valor m&eacute;dio de 21,4 (dp7,3), tradutor de uma 
	deteriora&#231;&atilde;o cognitiva leve. Foi igualmente aplicada a Escala de Depress&atilde;o Geri&aacute;trica<sup>&#91;7&#93; </sup>| <a href="#t4">TABELA IV</a> |,tendo&#45;se obtido um valor m&eacute;dio de 14 (dp 8,3) o que enquadra a nossa amostra de doentes com sintomatologia caracter&iacute;stica de depress&atilde;o severa.</p>
    ]]></body>
<body><![CDATA[<p>&nbsp;</p>
<a name="t4">
    <p><img src="/img/revistas/ang/v9n1/9n1a03t4.jpg" width="368" height="810"></p>
    
<p>&nbsp;</p>

	    <p>No que concerne &agrave; avalia&#231;&atilde;o da Qualidade de Vida Geral dos doentes com DAP o valor obtido foi de 41,05 (dp 10,89), que 
	comparativamente ao valor da qualidade de vida geral da popula&#231;&atilde;o portuguesa 71,51 (dp 13,30) se verifica uma redu&#231;&atilde;o 
	para aproximadamente metade nos doentes com DAP | <a href="#t5">TABELA V</a> |. Tendo em considera&#231;&atilde;o a qualidade de vida geral pr&eacute; &#150; tratamento e p&oacute;s&#45;tratamento, verifica&#45;se um incremento ligeiro na qualidade de vida geral p&oacute;s &#150; tratamento (38,3/41,05).</p>

	    <p>&#160;</p>
	<a name="t5">
	    <p><img src="/img/revistas/ang/v9n1/9n1a03t5.jpg" width="747" height="231"></p>

	    
<p>&#160;</p>

	    <p><b>DISCUSS&Atilde;O</b></p>

	    <p>Perceber verdadeiramente o impacto da DAP e do seu tratamento, na qualidade de vida do doente implica que para al&eacute;m de analisar os &iacute;ndices de tratamento tradicionais se deve suplementar essa mesma informa&#231;&atilde;o com avalia&#231;&otilde;es de vari&aacute;veis sociais e ps&iacute;quicas<sup>&#91;12&#93;</sup>. O doente com DAP necessita de uma extensa adapta&#231;&atilde;o no que concerne &agrave; altera&#231;&atilde;o de estilos de vida, nomeadamente o abandono do tabagismo, modifica&#231;&otilde;es dos h&aacute;bitos alimentares, regimes terap&ecirc;uticos r&iacute;gidos<sup>&#91;12,13&#93;</sup>. Os doentes perante estas altera&#231;&otilde;es podem experienciar sintomas de ansiedade e de depress&atilde;o, tal facto foi verificado no nosso estudo. Sendo que os nossos doentes se enquadraram na sintomatologia de depress&atilde;o severa, podendo este facto sugerir que a monitoriza&#231;&atilde;o apertada, por profissionais credenciados, no que concerne ao aparecimento e seguimento dos sintomas de depress&atilde;o pode ser ben&eacute;fico nos doentes com DAP.</p>

	    <p>Tendo em conta a natureza espec&iacute;fica deste tipo de patologia, a qual envolve, em muitos casos a incapacidade do doente para se deslocar e movimentar por si pr&oacute;prio e para realizar as suas actividades da vida quotidiana<sup>&#91;14&#93;</sup>, dificuldades estas, bem caracterizadas no nosso estudo pela aplica&#231;&atilde;o do &Iacute;ndice de Fragilidade de Groningen em que os condicionalismos da mobilidade e da forma f&iacute;sica se encontravam maioritariamente afectados.</p>

	    ]]></body>
<body><![CDATA[<p>&Eacute; genericamente assumido que a limita&#231;&atilde;o funcional motora do doente com DAP est&aacute; directamente correlacionado com a Qualidade de Vida Geral do doente, alias a melhoria desse condicionalismo funcional tem vindo a ser o grande crit&eacute;rio para o tratamento dos doentes com DAP<sup>&#91;13&#93;</sup>. No entanto para o doente em estadio avan&#231;ado da doen&#231;a (Isquemia Cr&iacute;tica) essa melhoria f&iacute;sica pode n&atilde;o estar associada a uma melhoria da Qualidade de Vida Geral percepcionada pelo doente<sup>&#91;13,15&#93;</sup>. Tal facto pode ser explicativo do ligeiro incremento obtido no nosso estudo pr&eacute; e p&oacute;s&#45;tratamento na qualidade de vida geral do doente.</p>

	    <p>Dadas as consequ&ecirc;ncias f&iacute;sicas, psicol&oacute;gicas e sociais que acompanham a DAP, &eacute; de esperar que a qualidade de vida geral dos doentes com DAP se encontre seriamente comprometida<sup>&#91;12&#93;</sup>. Os resultados do nosso estudo v&atilde;o ao encontro desta hip&oacute;tese, demonstrando que a PAD apresenta um impacto negativo significativo na qualidade de vida geral dos doentes.</p>

	    <p>Tendo em considera&#231;&atilde;o que este estudo levanta hip&oacute;teses e fornece informa&#231;&otilde;es para investiga&#231;&otilde;es futuras, ser&aacute; importante desenvolver pesquisas que permitam determinar estrat&eacute;gias espec&iacute;ficas para a melhoria da qualidade de vida destes doentes.</p>
	    <p>&nbsp;</p>
    <p><b>CONCLUS&Atilde;O</b></p>

	    <p>A doen&#231;a arterial perif&eacute;rica sendo uma doen&#231;a cr&oacute;nica e muitas vezes associada a consequ&ecirc;ncias mutiladoras de ordem f&iacute;sica torna compreens&iacute;vel e esperada a sua tradu&#231;&atilde;o negativa na qualidade de vida geral dos doentes.</p>

	    <p>O estudo da Qualidade de Vida Geral e das suas dimens&otilde;es nos doentes com DAP, poder&aacute; permitir o desenvolvimento de estrat&eacute;gias multidisciplinares ajustadas de forma a promover o processo de adapta&#231;&atilde;o do doente &agrave; sua doen&#231;a com a melhoria do seu bem&#45;estar.</p>
	    <p>&nbsp; </p>
	    <p><b>REFER&Ecirc;NCIAS BIBLIOGR&Aacute;FICAS</b></p>
	    <!-- ref --><p>&#91;1&#93; &#9;Hirsch AT, Criqui MH, Treat Jacobson et al, Peripheral arterial disease detection, awareness and treatment in primary care, JAMA, 11:1317 &#45;24, 2001&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S1646-706X201300010000300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>&#91;2&#93; &#9;L. Norgren, W.R.Hiatt, J.A. Dormandy et al, Inter&#45;Society Consensus for the management of Peripheral Arterial Disease ( TASC II) Eur J Vasc Endovasc Surg 33, S1 &#150; S75, 2007.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000083&pid=S1646-706X201300010000300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>

	    <!-- ref --><p>&#91;3&#93; &#9;S.M. Skevington, M. Lotfy, K.A. O&#8217;Connell, The World Health Organization&#8217;s WHOQOL&#45;BREF quality of life assessment: Psychometric properties and results of the international field trial, A Report from the WHOQOL Group, Quality of Life Research 13: 299&#150;310, 2004&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000085&pid=S1646-706X201300010000300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>&#91;4&#93; &#9;Hude Quan, Bing Li, Chantal M. Couris et al, Updating and Validating the Charlson Comorbidity Index and Score, American Journal of Epidemiology,10&#45;1093, 2010&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000086&pid=S1646-706X201300010000300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&#91;5&#93; &#9;Yeda Duarte, Claudia Andrade, Maria Lebr&atilde;o, O &Iacute;ndex de Katz na avalia&#231;&atilde;o da funcionalidade dos idosos, 41 (2):317&#45;25, Rev Esc Enferm USP,2007</p>

	    <!-- ref --><p>&#91;6&#93; &#9;Lawton, M.P., &amp; Brody, E.M. Assessment of older people: Self&#45;maintaining and instrumental activities of daily living. The Gerontologist, 9(3), 179&#45;186,1,1969&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000088&pid=S1646-706X201300010000300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>&#91;7&#93; &#9;Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol; 5:165&#45;73, 1986.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000089&pid=S1646-706X201300010000300007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>

	    <!-- ref --><p>&#91;8&#93; &#9;Guerreiro, M., Silva, A. P., Botelho, M. A., Leit&atilde;o, O., Castro&#45;Caldas, A., &amp; Garcia, C. Adapta&#231;&atilde;o a popula&#231;&atilde;o portuguesa da tradu&#231;&atilde;o do &#8220;Mini Mental State Examination&#8221; (MMSE). Revista Portuguesa de Neurologia, 1, 9&#45;10, (1994).    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000091&pid=S1646-706X201300010000300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>

	    ]]></body>
<body><![CDATA[<!-- ref --><p>&#91;9&#93; &#9;Adriano Vaz Serra, Maria Cristina Canavarro, M&aacute;rio R. Sim&otilde;es et al, Estudos Psicom&eacute;tricos do Instrumento de Avalia&#231;&atilde;o da Qualidade Vida da Organiza&#231;&atilde;o Mundial de Sa&uacute;de para Portugu&ecirc;s de Portugal, Psiquiatria Clinica,27: 41&#45;49 2006&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000093&pid=S1646-706X201300010000300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>&#91;10&#93;&#9;Gonz&aacute;lez, J., Palacios, E., Garc&iacute;a, , et al. Evaluaci&oacute;n de la fiabilidad y validez de una escala de valoraci&oacute;n social en el anciano. Primaria, Vol.23, pp. 434&#45;440, 1999.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000094&pid=S1646-706X201300010000300010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>

	    <p>&#91;11&#93; &#9;Steverink, N., Slaets, J.P.J., Schuurmans, H., &amp; Lis, M. van Measuring frailty:development and testing of the Groningen Frailty Indicator (GFI). The Gerontologist, 41, special issue 1, 236&#45;237, 2001.</p>

	    <p>&#91;13&#93; &#9;A. Hallin, D. Bergqvist, K. Fugl&#45;Meyer et all, Areas of Concer, Quality of life and Life satisfaction in Patients with Peripheral vascular disease, Eur J vasc Endovasc Surg,24:255&#45;263, 2002</p>

	    <p>&#91;14&#93; &#9;M. J. Smith, K. L.A. Borchard, E. Hinton et al, The Australian vascular Quality of Life Index Na Improved Clinical Quality of Life Tool For Peripheral vascular Disease, Eur J Vasc Endovasc Surg,34:199&#45;205 2007</p>

	    <p>&#91;15&#93; &#9;Kim G. Smolderen, Aline J. Pelle, Nina Kupper et al, impact of Peripheral arterial disease on health status: A comparison with chronic heart failure, J Vasc Surg,50:1391&#45;8 2009</p>

	    <p>&#91;16&#93; &#9;Samuel Wong, Jean Woo, Athena Hong et al, Clinically relevant depressive symptoms and peripheral arterial disease in eldery men and women. Results from a large cohort study in Southern China, J Psychosom Res,63:471&#45;476, 2007</p>

	
     ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Criqui]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[Treat]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Peripheral arterial disease detection, awareness and treatment in primary care]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2001</year>
<volume>11</volume>
<page-range>1317-24</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norgren]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Hiatt]]></surname>
<given-names><![CDATA[W.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Dormandy]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Inter-Society Consensus for the management of Peripheral Arterial Disease: TASC II]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2007</year>
<volume>33</volume>
<page-range>S1 - S75</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Skevington]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lotfy]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[O Connell]]></surname>
<given-names><![CDATA[K.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The World Health Organization s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial]]></article-title>
<source><![CDATA[A Report from the WHOQOL Group: Quality of Life Research]]></source>
<year>2004</year>
<edition>13</edition>
<page-range>299-310</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quan]]></surname>
<given-names><![CDATA[Hude]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Bing]]></given-names>
</name>
<name>
<surname><![CDATA[Couris]]></surname>
<given-names><![CDATA[Chantal M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Updating and Validating the Charlson Comorbidity Index and Score]]></article-title>
<source><![CDATA[American Journal of Epidemiology]]></source>
<year>2010</year>
<volume>10</volume>
<page-range>1093</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[Yeda]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[Claudia]]></given-names>
</name>
<name>
<surname><![CDATA[Lebrão]]></surname>
<given-names><![CDATA[Maria]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[O Índex de Katz na avaliação da funcionalidade dos idosos]]></article-title>
<source><![CDATA[Rev Esc Enferm]]></source>
<year>2007</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>317-25</page-range><publisher-name><![CDATA[USP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawton]]></surname>
<given-names><![CDATA[M.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Brody]]></surname>
<given-names><![CDATA[E.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assessment of older people: Self-maintaining and instrumental activities of daily living]]></article-title>
<source><![CDATA[The Gerontologist]]></source>
<year>1969</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-186</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sheikh]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Yesavage]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Geriatric depression scale (GDS): recent evidence and development of a shorter version]]></article-title>
<source><![CDATA[Clin Gerontol]]></source>
<year>1986</year>
<volume>5</volume>
<page-range>165-73</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerreiro]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[A. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Botelho]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Leitão]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Caldas]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Adaptação a população portuguesa da tradução do  Mini Mental State Examination: MMSE]]></article-title>
<source><![CDATA[Revista Portuguesa de Neurologia]]></source>
<year>1994</year>
<volume>1</volume>
<page-range>9-10</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[Adriano Vaz]]></given-names>
</name>
<name>
<surname><![CDATA[Canavarro]]></surname>
<given-names><![CDATA[Maria Cristina]]></given-names>
</name>
<name>
<surname><![CDATA[Simões]]></surname>
<given-names><![CDATA[Mário R.]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Estudos Psicométricos do Instrumento de Avaliação da Qualidade Vida da Organização Mundial de Saúde para Português de Portugal]]></article-title>
<source><![CDATA[Psiquiatria Clinica]]></source>
<year>2006</year>
<volume>27</volume>
<page-range>41-49</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Palacios]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Evaluación de la fiabilidad y validez de una escala de valoración social en el anciano]]></article-title>
<source><![CDATA[Primaria]]></source>
<year>1999</year>
<volume>23</volume>
<page-range>434-440</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steverink]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Slaets]]></surname>
<given-names><![CDATA[J.P.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schuurmans]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[van Lis]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Measuring frailty: development and testing of the Groningen Frailty Indicator (GFI)]]></article-title>
<source><![CDATA[The Gerontologist]]></source>
<year>2001</year>
<volume>41</volume>
<numero>special issue 1</numero>
<issue>special issue 1</issue>
<page-range>236-237</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hallin]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[D.]]></surname>
<given-names><![CDATA[Bergqvist]]></given-names>
</name>
<name>
<surname><![CDATA[Fugl-Meyer]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Areas of Concer, Quality of life and Life satisfaction in Patients with Peripheral vascular disease]]></article-title>
<source><![CDATA[Eur J vasc Endovasc Surg]]></source>
<year>2002</year>
<volume>24</volume>
<page-range>255-263</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Borchard]]></surname>
<given-names><![CDATA[K. L.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Hinton]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The Australian vascular Quality of Life Index Na Improved Clinical Quality of Life Tool For Peripheral vascular Disease]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2007</year>
<volume>34</volume>
<page-range>199-205</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smolderen]]></surname>
<given-names><![CDATA[Kim G.]]></given-names>
</name>
<name>
<surname><![CDATA[Pelle]]></surname>
<given-names><![CDATA[Aline J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kupper]]></surname>
<given-names><![CDATA[Nina]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Impact of Peripheral arterial disease on health status: A comparison with chronic heart failure]]></article-title>
<source><![CDATA[J Vasc Surg]]></source>
<year>2009</year>
<volume>50</volume>
<page-range>1391-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[Samuel]]></given-names>
</name>
<name>
<surname><![CDATA[Woo]]></surname>
<given-names><![CDATA[Jean]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[Athena]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinically relevant depressive symptoms and peripheral arterial disease in eldery men and women: Results from a large cohort study in Southern China]]></article-title>
<source><![CDATA[J Psychosom Res]]></source>
<year>2007</year>
<volume>63</volume>
<page-range>471-476</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
